Your shopping cart is currently empty

Anti-inflammatory agent 89 (5c) exhibits significant effects in alleviating pulmonary inflammation and restoring lung structure through its corticosteroid and H2S releasing components, making it a promising candidate for asthma research. It inhibits all characteristics of asthma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Anti-inflammatory agent 89 (5c) exhibits significant effects in alleviating pulmonary inflammation and restoring lung structure through its corticosteroid and H2S releasing components, making it a promising candidate for asthma research. It inhibits all characteristics of asthma. |
| In vitro | Anti-inflammatory agent 89 (100 μM, 24 h) did not reduce the viability of RBL-2H3 cells. |
| In vivo | Anti-inflammatory agent 89 (1-2 mg/kg, administered 30 minutes prior to sensitization on days 0 and 7, continuous for 21 days) suppresses asthmatic traits by targeting pulmonary inflammation in mice sensitized with Ovalbumin (OVA). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.